Survey of risk factors and renal disease in first-degree relatives of dialysis patients;Relevamiento de factores de riesgo y de enfermedad renal en familiares de pacientes en dialisis

Medicina

Volumn 67, Issue 1, 2007, Pages 8-18

  Inserra, Felipe ^a,b,c   De La Llave, German ^a   Alpino, Mariano ^b   Castagna, Rosa ^a   De La Fuente, Ismael ^b   Dorado, Enrique ^a   Norbis, Monica ^b   Pinelli, Liliana ^b   Puddu, Marcelo ^b   Santos, Juan Carlos ^b   Vivas, Nora ^b   Marelli, Cristina ^c  

^a Programa de Salud Renal FMC Argentina   (Argentina)

^b Fresenius Medical Care Argentina   (Argentina)

^c Fresenuis Medical Care ^*  (Argentina)

Author keywords

Chronic kidney disease; Family members; Hypertension; Microalbuminuria; Obesity; Proteinuria; Screening

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANALYTICAL PARAMETERS; ANTHROPOMETRY; ARGENTINA; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; FAMILY HISTORY; FAMILY STUDY; FEMALE; HEALTH SURVEY; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; INTERVIEW; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; NURSE TRAINING; OBESITY; POPULATION RESEARCH; PREVALENCE; PROTEINURIA; QUESTIONNAIRE; RELATIVE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; URINALYSIS; VOLUNTEER;

ADOLESCENT; ADULT; ARGENTINA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CREATININE; CROSS-SECTIONAL STUDIES; FAMILY HEALTH; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; NUCLEAR FAMILY; OBESITY; PROTEINURIA; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SMOKING;

EID: 33947714033     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. INCUCAI. Sistema Nacional de Información; Registro Nacional de Insuficiencia Renal Cronica Terminal, 2005. Disponible en: https://irct.incucai.gov.ar
2. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 2005; (Suppl 98): S7-S10.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.
4. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005; 293: 1737-45.
5. Hennekens CH. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 1998; 97: 1095-102.
6. Canto JG, Iskandrian AE. Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA 2003; 290: 947-9.
7. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290: 891-7.
8. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290: 898-904.
9. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 1979; 59: 8-13.
10. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care 1979; 2: 120-6.
11. Wilhelmsson C, Vedin JA, Elmfeldt D, et al. Smoking and myocardial infarction. Lancet 1975; 1: 415-20.
12. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro, S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985; 313: 1511-4.
13. Jungers P, Zingraff J, Albouze G, Chauveau P. Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant 1993; 8: 1089-93.
14. McLaughlin K, Manns B, Culleton B, Donaldson C, Taub K. An economic evaluation of early versus late referral of patients with progressive renal insufficiency. Am J Kidney Dis 2001; 38: 1122-8.
15. Levin A. Consequences of late referral on patient outcomes. Nephrol Dial Transplant 2000; 15 (Suppl 3): 8-13.
16. Gallego E, Lopez A, Lorenzo I, et al. Influence of early or late referral to nephrologist over morbidity and mortality in hemodialysis. Nefrología 2003; 23: 234-42.
17. Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT. Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transplant 2004; 19: 1808-14.
18. Satko SG. Freedman BI. The importance of family history on the development of renal disease. Curr Opin Nephrol Hypertens 2004; 13: 337-41.
19. Satko SG, Freedman BI. Sceening for subclinical nephropathy in relatives of dialysis patients. Sem Dial 2001; 14: 311-3.
20. Bowden DW, Colicigno CJ, Langefeld CD, et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int 2004; 66: 1517-26.
21. Sale MM, Freedman BI, Langefeld CD, et al. A genomewide scan for type 2 diabetes in african-american families reveals evidence for a locus on chromosome 6q. Diabetes 2004; 53: 830-7.
22. Jurkovitz C, Franch H, Shoham D, Bellenger J, McClellan W. Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis 2002; 40: 1173-8.
23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Part 4-Definition and classification of chronic kidney disease. Am J Kidney Dis 2002; 39 (suppl 1): 546-64.
24. KDQQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39 (Suppl 2): S1-S246.
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
26. National Kidney Foundation. Web site: http://www.kidney.org. Consultado enero 2005.
27. Rao M, Kausz AT, Mitchell D, et al. The Study of Treatment for Renal Insufficiency: Data and Evaluation (STRIDE), a national registry of chronic kidney disease. Semin Dial 2002; 15: 366-9.
28. Patel SS, Kimmel PL, Singh A. New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. Semin Nephrol 2002; 22: 449-58.
29. Eknoyan G. Meeting the challenges of the new K/DOQI guidelines. Am J Kidney Dis. 2003; 41(Suppl 5): 3-10.
30. Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66: 1310-4.
31. Bergman S, Key BO, Kirk KA, Warnoc DG, Rostand SG. Kidney disease in the first-degree relatives of African-Americans With hypertensive end-stage renal disease. Am J Kidney Dis 1996; 27: 341-6.
32. Seaquist ER, Goetz FC, Rich S, Barboza J. Familial clustering of diabetic kidney disease evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-5.
33. Chandie Shaw PK, van Es LA, Paul LC, Rosendaal FR, Souverijn JH, Vandenbroucke JP. Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy. Diabetologia 2003; 46: 618-24.
34. Freedman BL, Wilson CH, Spray BJ, Tuttle AB, Olorenshaw IM, Kammer GM. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997; 79: 729-32.
35. Ghavari AG, Yan Y, Scolari F, et al. IgA nephropathy the most common cause of glomerulophritis is linked to 6q22-23. Nat Genet 2000; 26: 354-7.
36. Schena FP, Cerullo G, Rossini M, Lanzilotta SG, D'Altri C, Manno C. Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol. 2002; 13: 453-60.
37. Mathis BJ, Kim SH. Calabrese MH, Seidman JG, Seidman CE, Pollack MR. A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13.Kidney Int 1998; 53: 282-6.
38. Freedman BI, Volkova NV, Satko SG, et al. Population-Based Screening for Family History of End-Stage Renal Disease among Incident Dialysis Patients. Am J Nephrol. 2005; 25: 529-35.
39. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003; 41: 1-12.
40. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening; Results from the NHANES III. Kidney Int 2002, 61: 2165-75.
41. Inserra F, Cornelio C, Daverio S, Diehl, S, Samarelli N, Díaz A. Estratificación de la función renal de la población con cobertura social en la ciudad de Buenos Aires. Nefrología Argentina 2003, 1: 44 (abstract).
42. Encuesta Nacional de Salud. Ministerio de Salud de Chile. 2004. En: http//epi.minsal.cl
43. O'Dea DF, Murphy SW, Heferton D, Parfrey PS. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: A population based study. Am Journal Kidney Dis 1998; 32: 794-801.
44. Freedman BI, Soucie JM, Stone SM, Pegram S. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis. 1999; 34: 254-8.
45. Canani LH, Gerchman F, Gross JL. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes. 1999; 48: 909-13.
46. Freedman BI. Familial aggregation of end-stage renal failure: aetiological implications. Nephrol Dial Transplant. 1999; 14: 295-7.
47. Satko SG, Freedman BI. Screening for subclinical nephropathy in relatives of dialysis patients. Semin Dial. 2001; 14: 311-3.
48. Thompson CF, Simmons D, Collins JF, Cecil A. Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus. Diabet Med 2001; 18: 40-6.
49. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995; 25: 710-3.
50. Locatelli F, Marcelli D, Comelli M, et al. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Nephrol Dial Transplant 1996; 11: 461-7.
51. Echeverria RF, Camacho RO, Carbajal HA, et al. Prevalence of arterial hypertension in La Plata, Argentina. Medicina (Buenos Aires). 1988; 48: 22-8.
52. Nigro D, Vergottini JC, Kuschnir E, et al. Epidemiología de la Hipertensión Arterial en la Ciudad de Córdoba. Rev Fed Arg Cardiol 1999; 28: 69-75.
53. Limansky RB, Farías JA, Cámera MI. Arterial hypertension prevalence in Argentina. J Hypertens 1992; 10 (Suppl 4): S37 (abstract).
54. Lúquez H, Madoery RJ, de Loredo L, et al. Prevalencia de hipertensión arterial y factores de riesgo asociados. Estudio Dean Funes (Provincia de Córdoba - Argentina). Rev Fed Arg Cardiol 1999; 28: 93-104.
55. Fernández Contreras R, Terragno N, Gómez Llambi H. Prevalencia, control y tratamiento de la Hipertensión Arterial. XVII Congreso Interamericano de Cardiología. 1999; Septiembre.
56. Piscorz Daniel. Factores de riesgo en la Ciudad de Rosario. Resultados del estudio FAROS. Rev Fed Arg Cardiol 1999; 64: 245-51.
57. Ramos Felipe et al. Consenso Latinoamericano sobre Hipertensión Arterial. J Hypertens 2001; 6: 1-28.
58. McColl P, Amador M, Aros J, Lastra A, Pizarro C. Prevalencia de factores de riesgo de enfermedades crónicas no transmisibles en estudiantes de medicina de la Universidad de Valparaiso. Rev Chil Pediatr 2002; 73: 478-82.
59. Ennis IL, Gende OA, Cingolani HE. Prevalence of hypertension in 3154 young students. Medicina (Buenos Aires). 1998; 58: 483-91.
60. Craig, JC, Barratt A, Cumming R, Irwig L, Salkeld G. Feasibility study of the early detection and treatment of renal disease by mass screening. Intern Med J 2002; 32: 6-14.
61. Atkins RC, Polkinghorne KR, Briganti EM, Shaw JE, Zimmet PZ, Chadban SJ. Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int 2004; Suppl.(92): S22-S24.
62. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 2002; 61: 2165-75.
63. Bonet J, Vila J, Alsina MJ, Ancochea L, Romero R; Grupo Baetulo. Prevalence of microalbuminuria and association with cardiovascular risk factors in a Spanish Mediterranean area. Med Clin (Barc). 2001; 28;116: 573-4.
64. Liese AD, Hense HW, Doring A, Stieber J, Keil U. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 2001; 15: 799-804.
65. Diercks GF, van Boven AJ, Hillege HL, et al. Microalbuminuria was associated with ischemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of Renal and Vascular Endstage Disease) Eur Hearth J 2000; 21: 1922-7.
66. Hillege HL, Fidler V, Diercks GF, et al. Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-82.
67. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-69.
68. Litwak LE, Graffigna MN, Abdala MM, et al. Prevalencia de factores de riesgo cardiovascular en sujetos sanos. Estudio epidemiológico multicéntrico. (Resultados preliminares). Rev Argent Endocr y Metab 2004; 41: 206-13.
69. Kovalskys I, Bay L, Herscovici CR, Berner E. Prevalencia de obesidad en la población de 10 a 19 años en la consulta pediátrica. Arch Argent Pediatr 2003; 101: 441-7.